Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01147874 · ClinicalTrials.gov registry record · Phase 4
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,013
- Enrollment target
NCT01147874 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 1,013 participants.
The verdict
NCT01147874, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,013 participants
- Enrollment target
Study Summary
This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a dermatologist at visit 1 and by a rheumatologist at visit 2. A subset of subjects will then go on to visit 3 for imaging procedures (x-ray, MRI, and ultrasound).
Interventions
- PROCEDURE lab draws and imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,013 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01147874
The ClinicalTrials.gov registry entry for NCT01147874 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,013 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lab draws and imaging is the first listed.
NCT01147874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01147874 about?
NCT01147874 is a clinical study titled "Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice". This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a dermatologist at visit 1 and by a rheumatologist at visit 2. A subset of subjects will then go on to...
What is the current status of trial NCT01147874?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,013 participants. The study started on 2010-08. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01147874?
The interventions under investigation include: lab draws and imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01147874?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.